Characterization and treatment of resistant hypertension. - Wikidata - wikimedia - TriplyDB

Characterization and treatment of resistant hypertension.

Characterization and treatment of resistant hypertension.

http://www.wikidata.org/entity/Q33591983

about

Non drowsy obstructive sleep apnea as a potential cause of resistant hypertension: a case report Common secondary causes of resistant hypertension and rational for treatment Incidence and prognosis of resistant hypertension in hypertensive patients.An observational study of hypertension treatment and patient outcomes in a primary care setting.The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension Overview of resistant hypertension: A glimpse of the cardiologist's current standpoint.Resistant hypertension and obstructive sleep apnea in the setting of kidney disease Blood pressure changes after renal denervation at 10 European expert centers.Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor.Resistant hypertension: current status, future challenges.Characteristics and future cardiovascular risk of patients with not-at-goal hypertension in general practice in France: the AVANT'AGE study.Age- and gender-related characteristics of obstructive sleep apnea.Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience.The Effects of Aldosterone Antagonists in Patients With Resistant Hypertension: A Meta-Analysis of Randomized and Nonrandomized Studies.Does experimental paradoxical sleep deprivation (EPSD) is an appropriate model for evaluation of cardiovascular complications of obstructive sleep apnea?Resistant Hypertension.

P2860

Q34245305-E69F7DD9-17D6-48BA-8D90-6791A0767264 Q34669789-BBAF95B4-C410-42A3-9799-C63295708AC7 Q35932321-57551F59-656D-4449-A6A2-130D7ABCF0C8 Q35958431-BDB8B3AD-C098-47C9-9DC9-643EC1B60BD1 Q36178338-8106253E-E836-4CF1-BA5E-03BE8E51EC15 Q36285503-13E06316-4A80-4096-8E5A-3687673047CC Q37167764-B3C9023A-E3A6-4620-9E53-1AFC233EBA9E Q37598844-09D65156-BE7A-4701-B581-FFC82F0E4187 Q38179027-40AD8488-1CEC-4DD9-A915-C2118D3B3039 Q38208867-FEEF401F-4DE7-4EC7-AC8E-D2A076641422 Q39440922-4A33A158-725B-4E77-8B30-A62E4B0A9700 Q44642853-7BB7653D-456D-4FCC-A40E-98C1B1C6C6DC Q44918934-4F45478F-44AE-4114-8FAF-160B878B4CC9 Q45011033-25DBD5CE-2656-4BE1-9ABD-A102D8584EFD Q47905401-1CC14A12-0E37-4C82-9986-5FB295D37C7C Q50861962-964553CC-F1B0-431E-9535-50FE8F68427C

P2860

Characterization and treatment of resistant hypertension.

http://www.wikidata.org/entity/Q33591983

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Characterization and treatment of resistant hypertension.

@ast

Characterization and treatment of resistant hypertension.

@en

type

label

Characterization and treatment of resistant hypertension.

@ast

Characterization and treatment of resistant hypertension.

@en

prefLabel

Characterization and treatment of resistant hypertension.

@ast

Characterization and treatment of resistant hypertension.

@en

P1433

Q33591983-4D7015DE-16BA-42F4-B794-AB4E68CED39A

P1476

Q33591983-E0FED08A-03A7-42BD-9ECF-B674AF6FEAD9

P2093

Q33591983-10FEA1E0-BB52-44F8-91F8-B662428E0B77

Q33591983-23A2EBC7-B56D-45DB-8D72-5BB9BFBF468C

Q33591983-A25C6F35-EBF8-4304-8FBA-95DDC6730DE6

P2860

Q33591983-1255C12A-332A-47EE-BB7F-C0B146AE2B5A

Q33591983-1AD766FF-6EE9-4491-BD2D-BC6FC7EB9862

Q33591983-1DDEA7CC-8376-424B-9D4F-D98DAFF76C16

Q33591983-1E183824-D888-478A-9527-98B3C0FE5B15

Q33591983-22D11E40-8AC7-4157-9964-7C2F147FBCDA

Q33591983-318861E6-D1E3-4D2F-AE10-10E201AA9574

Q33591983-3231E4AE-4E3D-43FE-AE67-9577EF8C731D

Q33591983-34D3E518-52CE-4E09-ACC5-E9D5902054D3

Q33591983-382DAF6C-2E39-45CA-B578-3E33FDE1FD42

Q33591983-3E1E6836-8275-4075-B2CE-3BA1B4808A03

P2888

Q33591983-57C1A82B-7F9C-4A26-AC38-8FD5925606DC

P304

Q33591983-4C4E2B3A-5767-4F95-BD25-E76DBE759E44

P31

Q33591983-F396C966-B9B3-4BF9-9633-002ED339FFF9

P356

Q33591983-BE89DAB5-AFC4-4CB0-B5FE-C492E5AFA714

P433

Q33591983-8FB280D9-53AD-48C2-8D08-93EF7D564A99

P478

Q33591983-8BCCE3D2-B0FE-48A7-8D03-3BE92175D9BB

P577

Q33591983-F765DA2F-C59C-4CE7-9C0A-1F89CFBEAD39

P5875

Q33591983-928AE4ED-445A-4698-A128-C5E6E9387E22

P6179

Q33591983-4A4ADC23-9670-4FF7-B349-8EE2F5FA086F

P698

Q33591983-94D57C9B-80C6-4123-80A7-65CA68CB347E

P932

Q33591983-C0C36DB6-0B72-444F-A960-18217C8684E3

P356

S11886-009-0059-Z

P1433

Current cardiology reports

P1476

Characterization and treatment of resistant hypertension.

@en

P2093

David A Calhoun

http://www.w3.org/2001/XMLSchema#string

Mustafa I Ahmed

http://www.w3.org/2001/XMLSchema#string

Roberto Pisoni

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Phaeochromocytoma.

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

P2888

s11886-009-0059-z

P304

407-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-009-0059-Z

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38042963

http://www.w3.org/2001/XMLSchema#string

P6179

1012426808

http://www.w3.org/2001/XMLSchema#string

P698

19863864

http://www.w3.org/2001/XMLSchema#string

P932

2806815

http://www.w3.org/2001/XMLSchema#string